Eptifibatide Intravenous and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Eptifibatide Intravenous and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: eptifibatide
Brand name: Integrilin
Synonyms: Eptifibatide
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Eptifibatide Intravenous-Insulin degludec
- Eptifibatide Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Eptifibatide Intravenous-Insulin Degludec (U-100) Vials
- Eptifibatide Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Eptifibatide Intravenous-Insulin degludec and liraglutide
- Eptifibatide Intravenous-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Epy Kit
- Insulin aspart, recombinant Subcutaneous-Epzicom
- Insulin aspart, recombinant Subcutaneous-EQ Antibiotic + Pain Relief
- Insulin aspart, recombinant Subcutaneous-EQ Children’s Cold
- Insulin aspart, recombinant Subcutaneous-EQ Cold Plus
- Insulin aspart, recombinant Subcutaneous-EQ Cold Relief Complete